Exact Mass: 384.20489680000003
Exact Mass Matches: 384.20489680000003
Found 500 metabolites which its exact mass value is equals to given mass value 384.20489680000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rhynchophylline
C22H28N2O4 (384.20489680000003)
Rhynchophylline is a member of indolizines. It has a role as a metabolite. Rhynchophylline is a natural product found in Uncaria tomentosa, Mitragyna inermis, and other organisms with data available. See also: Cats Claw (part of). A natural product found in Uncaria macrophylla. Annotation level-1 Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research. Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research.
IsoRhy
C22H28N2O4 (384.20489680000003)
Isorhynchophylline is a member of indolizines. It has a role as a metabolite. Isorhynchophylline is a natural product found in Uncaria tomentosa, Mitragyna inermis, and other organisms with data available. See also: Cats Claw (part of). A natural product found in Uncaria macrophylla. Isorhynchophylline is an alkaloid compound isolated from Uncaria. It can lower blood pressure, relax blood vessels, and protect nerves from damage caused by local ischemia. Isorhynchophylline is an alkaloid compound isolated from Uncaria. It can lower blood pressure, relax blood vessels, and protect nerves from damage caused by local ischemia.
Megestil
CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9660; ORIGINAL_PRECURSOR_SCAN_NO 9655 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9556; ORIGINAL_PRECURSOR_SCAN_NO 9555 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9613; ORIGINAL_PRECURSOR_SCAN_NO 9611 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9650; ORIGINAL_PRECURSOR_SCAN_NO 9648 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9684; ORIGINAL_PRECURSOR_SCAN_NO 9681 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9604; ORIGINAL_PRECURSOR_SCAN_NO 9603 D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D019167 - Appetite Stimulants C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone CONFIDENCE standard compound; INTERNAL_ID 2814 CONFIDENCE standard compound; INTERNAL_ID 8750 D000970 - Antineoplastic Agents
Bufogein
Bufogenin is a steroid lactone of Chan su (toad venom), a Chinese medicine obtained from the skin venom gland of toads. A specific Na/K-ATPase protein inhibitor, it is used as a cardiotonic and central nervous system (CNS) respiratory agent, an analgesic and anesthetic, and as a remedy for ulcers. It has a role as an EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor. It is a steroid lactone and an epoxy steroid. It is functionally related to a bufanolide. Resibufogenin is a natural product found in Sclerophrys mauritanica, Bufo gargarizans, and other organisms with data available. Bufogenin is a bufadienolide toxin originally isolated from the venom of the Chinese toad Bufo gargarizans; it is also one of the glycosides in the traditional Chinese medicine ChanSu, with potential cardiotonic activity. Although the mechanism of action of bufogenin is still under investigation, this agent is a specific Na+/K+-ATPase inhibitor and has been shown to reduce blood pressure in a rat model of preeclampsia. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents C471 - Enzyme Inhibitor Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.
16-Methoxy-2,3-dihydro-3-hydroxytabersonine
C22H28N2O4 (384.20489680000003)
Ethynodiol Diacetate
Ethynodiol Diacetate is only found in individuals that have used or taken this drug. It is a synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive. [PubChem]Binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like Ethynodiol Diacetate will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01294
ST 24:5;O4
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Same as: D01617 D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01294
Estra-1,3,5(10)-triene-3,16alpha-diol dipropionate
Acequinocyl
An acetate ester consisting of 1,4-naphthoquinone bearing acetoxy and dodecyl substituents at positions 2 and 3 respectively.
Roxatidine acetate hydrochloride
C19H29ClN2O4 (384.18157440000004)
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists Roxatidine Acetate Hydrochloride is a potent, selective, competitive and orally active histamine H2-receptor antagonist. Roxatidine Acetate Hydrochloride has antisecretory potency against gastric acid secretion. Roxatidine Acetate Hydrochloride can also suppress inflammatory responses and can be used for gastric and duodenal ulcers research. Roxatidine Acetate Hydrochloride has antitumor activity[1][2][3].
Artesunate
Artesunate is an artemisinin derivative that is the hemisuccinate ester of the lactol resulting from the reduction of the lactone carbonyl group of artemisinin. It is used, generally as the sodium salt, for the treatment of malaria. It has a role as an antimalarial, a ferroptosis inducer and an antineoplastic agent. It is an artemisinin derivative, a sesquiterpenoid, a dicarboxylic acid monoester, a cyclic acetal, a semisynthetic derivative and a hemisuccinate. Artesunate is indicated for the initial treatment of severe malaria. The World Health Organization recommends artesunate as first line treatment for severe malaria. Artesunate was developed out of a need for a more hydrophilic derivative of [artemisinin]. Artesunate was granted FDA approval on 26 May 2020. Artesunic acid is a natural product found in Artemisia apiacea, Acronychia pubescens, and Artemisia carvifolia with data available. Artesunate is a water-soluble, semi-synthetic derivative of the sesquiterpine lactone artemisinin with anti-malarial, anti-schistosomiasis, antiviral, and potential anti-neoplastic activities. Upon hydrolysis of artesunates active endoperoxide bridge moiety by liberated heme in parasite-infected red blood cells, reactive oxygen species and carbon-centered radicals form, which have been shown to damage and kill parasitic organisms. Additionally, in vitro studies demonstrate that this agent induces DNA breakage in a dose-dependent manner. Artesunate has also been shown to stimulate cell differentiation, arrest the cell cycle in the G1 and G2/M phases, inhibit cell proliferation, and induce apoptosis through mitochondrial and caspase signaling pathways. Artemisinin is isolated from the plant Artemisia annua. artesunate is a mineral. A water-soluble, semi-synthetic derivative of the sesquiterpene lactone artemisinin with anti-malarial, anti-schistosomiasis, antiviral, and potential anti-neoplastic activities Artesunate is part of the artemisinin group of drugs that treat malaria. It is a semi-synthetic derivative of artemisinin that is water-soluble and may, therefore, be given by injection. It is on the World Health Organizations List of Essential Medicines, the most effective and safe medicines needed in a health system (DrugBank). P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides D000970 - Antineoplastic Agents Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1). Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1).
Cinnzeylanol
Constituent of the dried bark of Cinnamomum zeylanicum (cinnamon) and of Cinnamomum cassia (Chinese cinnamon) [CCD]. Cinnzeylanol is found in chinese cinnamon, ceylon cinnamon, and herbs and spices. Cinnzeylanol is found in ceylan cinnamon. Cinnzeylanol is a constituent of the dried bark of Cinnamomum zeylanicum (cinnamon) and of Cinnamomum cassia (Chinese cinnamon)
(6beta,7alpha,12beta,13beta)-7-Hydroxy-11,16-dioxo-8,14-apianadien-22,6-olide
(6beta,7beta,12beta,13beta)-7-Hydroxy-11,16-dioxo-8,14-apianadien-22,6-olide is found in herbs and spices. (6beta,7beta,12beta,13beta)-7-Hydroxy-11,16-dioxo-8,14-apianadien-22,6-olide is isolated from sage. Isolated from sage. (6beta,7alpha,12beta,13beta)-7-Hydroxy-11,16-dioxo-8,14-apianadien-22,6-olide is found in herbs and spices.
Armillarivin
Armillarivin is found in mushrooms. Armillarivin is a metabolite of Armillaria mellea (honey mushroom). Metabolite of Armillaria mellea (honey mushroom). Armillarivin is found in mushrooms.
Bortezomib
C19H25BN4O4 (384.19687600000003)
Bortezomib (originally PS-341 and marketed as Velcade by Millennium Pharmaceuticals) is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XG - Proteasome inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor D000970 - Antineoplastic Agents C471 - Enzyme Inhibitor
20-Trihydroxy-leukotriene-B4
20-trihydroxy-leukotriene-B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region, and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by omega-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the omega-carboxy position and after CoA ester formation (PMID: 7649996, 17623009, 2853166, 6088485). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 20-trihydroxy-leukotriene-B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996, 17623009, 2853166, 6088485)
repaglinide aromatic amine
C22H28N2O4 (384.20489680000003)
repaglinide aromatic amine is a metabolite of repaglinide. Repaglinide is for the treatment of type II diabetes. It is supplied by Novo Nordisk. It is sold in Japan by Dainippon Sumitomo Pharma. Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs. (Wikipedia)
1-(2-(4-Morpholinyl)ethyl)-3-(1-naphthoyl) indole
C25H24N2O2 (384.18376839999996)
7-[(1S,2R,3R,4R)-3-(3-Hydroxy-4-phenylpent-1-enyl)-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid
Bufogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents
Estradiol dipropionate
Isorhynchophylline
C22H28N2O4 (384.20489680000003)
Istradefylline
Magestin
[(2S,3As,7aS)-Octahydro-1-[[(1R,2R)-2-phenylcyclopropyl]carbonyl]-1H-indol-2-yl]-3-thiazolidinyl--methanone
1,5-Dihydroxy-4,8-bis[2-(methylamino)ethylamino]anthracene-9,10-dione
Schiff base
C19H24N6O3 (384.19097939999995)
Corynoxine
C22H28N2O4 (384.20489680000003)
Corynoxine is a member of indolizines. It has a role as a metabolite. Corynoxine is a natural product found in Mitragyna speciosa, Uncaria attenuata, and Uncaria macrophylla with data available. A natural product found in Uncaria macrophylla. Corynoxine, a tetracyclic oxindole alkaloid, is isolated from the hooks of Uncaria rhynchophylla. Corynoxine is a natural autophagy enhancer that promotes the clearance of alpha-synuclein via Akt/mTOR pathway[1]. Corynoxine, a tetracyclic oxindole alkaloid, is isolated from the hooks of Uncaria rhynchophylla. Corynoxine is a natural autophagy enhancer that promotes the clearance of alpha-synuclein via Akt/mTOR pathway[1]. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer.
Corynoxine B
C22H28N2O4 (384.20489680000003)
A natural product found in Uncaria macrophylla. Corynoxine B is a member of indolizines. It has a role as a metabolite. Corynoxine B is a natural product found in Mitragyna speciosa and Uncaria macrophylla with data available. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer.
5-hydroxy-4-isopropyl-1-methyl-7-(3-oxobutyl)bicyclo[4.1.0]hept-3-yl cinnamate
Decahydro-alpha,4a-dimethyl-8-methylene-7-(1-oxo-3-phenylpropoxy)-2-naphthaleneacetic acid
19-Hydroxy-19,20-Dihydrovincamajine
C22H28N2O4 (384.20489680000003)
16-Methoxy-2,3-dihydro-3hydro-3-hydroxytabersoine
C22H28N2O4 (384.20489680000003)
2-Pyrrolidinecarboxamide, N-(2-benzoylphenyl)-1-(phenylmethyl)-
C25H24N2O2 (384.18376839999996)
5-[(Z)-12-(3,5-dihydroxyphenyl)dodec-8-enyl]benzene-1,3-diol
4MeC13SPC
Literature spectrum; CONFIDENCE Identification confirmed with Reference Standard (Level 1); Digitised from figure: approximate intensities
8-(4-Hydroxycinnamoyl)-(4beta,5alpha,8alpha)-1(10)-Guaiaene-8,11-diol|<4S,5S,7S,8S>-8-p-Coumaroyloxy-1(10)-guaien-11-ol|[4S,5S,7S,8S]-8-p-Coumaroyloxy-1(10)-guaien-11-ol
plakortolide Q
An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.
16-acetoxy-17-methoxy-coryn-16-en-9-ol|Gambirin
C22H28N2O4 (384.20489680000003)
(1alpha,2beta,3beta.5beta.6beta,7alpha,10alpha,14beta,16alpha)-2,3-Epoxy-5,6,7,10,14,16-grayanotoxanexol|Pieristoxin H|pieritoxin H
18-hydroxy-17-methoxy-yohimbane-16-carboxylic acid methyl ester|Deserpidinsaeure-methylester|Deserpidsaeure-methylester|Deserpinsaeure-methylester|ent-18alpha-Hydroxy-17beta-methoxy-15beta-yohimban-16alpha-carbonsaeure-methylester|ent-18alpha-hydroxy-17beta-methoxy-15beta-yohimban-16alpha-carboxylic acid methyl ester|Methyl deserpidate
C22H28N2O4 (384.20489680000003)
(16E)-9-Hydroxy-17-methoxy-coryn-16-en-16-carbonsaeure-methylester|(16E)-9-hydroxy-17-methoxy-coryn-16-ene-16-carboxylic acid methyl ester|Gambirine
C22H28N2O4 (384.20489680000003)
19-hydroxy-13-methoxy-ibogamine-18-carboxylic acid methyl ester|19-Hydroxy-isovoacangin|3-R/S-hydroxy-isovoacangine
C22H28N2O4 (384.20489680000003)
1beta,6alpha-dihydroxy-8alpha-(3-hydroxy-isobutanoyloxy)-11-carboxymethyl-eudesm-11(13)-en-4-one
(16S,19E)-N1-(hydroxymethyl)isositsirikine|methyl (2S)-2-[(2R,3E,12bS)-3-ethylidene-1,2,3,4,6,7,12,12b-octahydro-12-(hydroxymethyl)indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C22H28N2O4 (384.20489680000003)
12-Methoxy-vincamin|14-hydroxy-12-methoxy-14,15-dihydro-eburnamenine-14-carboxylic acid methyl ester|Methoxy-12-vincamin
C22H28N2O4 (384.20489680000003)
1-(2-Hydroxy-6-methoxyphenyl)-9-(1,3-benzodioxol-5-yl)nonan-1-one
isobutyl 13-(1,3-benzdioxolo-5)trideca-2E,4E,12E-trienoate
3beta,16beta-dihydroxy-bufa-8(14),20,22-trienolide
1-(2,6-Dihydroxy-4-methoxyphenyl)-11-phenyl-1-undecanone|11-phenylundecanoyl-2,6-dihydroxy-4-methoxybenzene
3alpha-(2,3-epoxy-2-methylbutyryloxy)-4alpha,7alpha,11-trihydroxyeudesman-8-one
N(a)-Acetyl-11-methoxystrychnosplendine|Na-Acetyl-11-methoxystrychnosplendine
C22H28N2O4 (384.20489680000003)
(all-Z)-form-1-(2,4,6-Trihydroxyphenyl)-6,9,12,15-octadecatetraen-1-one,|phloroglucinol
lehualide E
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by methoxy groups at positions 3 and 4, a methyl group at position 5 and a (2E)-3-methyl-9-phenylnon-2-en-1-yl group at position 6. It has been isolated from the marine sponge of the genus Plakortis.
Lehualide H
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by methoxy groups at positions 3 and 4, a methyl group at position 5 and a 10-(acetylsulfanyl)decyl group at position 6. Isolated from the marine sponge of the genus Plakortis, it exhibits cytotoxicity against human promyeloid leukemic HL-60 cells.
(9S,9aR)-9-hydroxy-9a-methyl-3-octanoyl-6-((E)-prop-1-enyl)-9,9a-dihydro-2H-furo[3,2-g]isochromen-2-one|monaphilol A
20(10->5)abeo-4,12-diacetoxy-4,5-secoabieta-5(10),6,8,11,13-pentaene|8-[4-(acetyloxy)-4-methylpentyl]-7-methyl-3-(1-methylethyl)naphthalen-2-yl acetate|diacetylcalocediol
Methyl 11-methoxy-19-methyloxayohimban-16-carboxylate #
C22H28N2O4 (384.20489680000003)
(1R,4E,8R,10R)-8-O-[(E)-p-coumaroyl]-1,10-epoxyhumula-4(5)-en-8-ol
(1E,4R,5R,8R)-8-O-[(E)-p-coumaroyl]-4,5-epoxyhumula-1(10)-en-8-ol
(1E,5R,8R)-8-O-[(E)-p-coumaroyl]-5-hydroxyhumula-1(10),4-(15)-dien-8-ol
(1S,3R,5R,7aR)-4-[(acetoxy)methyl]-1,3,5,7a-tetrahydro-7-(hydroxymethyl)-3,5-dimethoxycyclopenta[c]pyran-1-yl 3-methylbutanoate|jatairidoids A
(Z)-10-demethoxy-12-hydroxygeissovelline
C22H28N2O4 (384.20489680000003)
7alpha-hydroxy-11,16-diketo-apian-8,14(15)-dien-(20,6)-olide
2,6-dihydroxy-4-[(E)-7-hydroxy-3,7-dimethylocta-2-enyloxy]benzophenone
3-O-acetyl-4,5-O-(3-methylvaleryl)-and propionylshikimic acid methyl ester|3-O-acetyl-4,5-O-<3-methylvaleryl>-and propionylshikimic acid methyl ester
(6R,11S,13S)-6,11,13-trihydroxy-2,3-seco-14-labden-2,8-olid-3-oic acid|rhizophorin A
O-(4-Methoxybenzoyl)-2alpha-2-Hydroxy-1(10)-oplopene-4,9-dione
(19R)-1-acetyl-17,19-epoxy-11-methoxy-curan-12-ol|12-hydroxy-11-methoxy-spermostrychnine|12-Hydroxy-11-methoxyspermostrychnin
C22H28N2O4 (384.20489680000003)
jerantinine E
C22H28N2O4 (384.20489680000003)
An indole alkaloid that is the 14-15-dihydro derivative of jerantinine A. Isolated from Tabernaemontana corymbosa, it exhibits cytotoxicity against human KB cells.
rhyncophylline
C22H28N2O4 (384.20489680000003)
Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research. Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research.
Resibufogenin
Annotation level-1 Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.
Megestrol acetate
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D019167 - Appetite Stimulants C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D000970 - Antineoplastic Agents
Enalaprilat Dihydrate
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Roxatidine acetate HCl
C19H29ClN2O4 (384.18157440000004)
Roxatidine Acetate Hydrochloride is a potent, selective, competitive and orally active histamine H2-receptor antagonist. Roxatidine Acetate Hydrochloride has antisecretory potency against gastric acid secretion. Roxatidine Acetate Hydrochloride can also suppress inflammatory responses and can be used for gastric and duodenal ulcers research. Roxatidine Acetate Hydrochloride has antitumor activity[1][2][3].
Artesunate
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1). Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1).
[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
C24H32O4_2-Propenoic acid, 3-phenyl-, (1R,2R,3S,4R,6E,10S)-2-hydroxy-6,10-dimethyl-3-(1-methylethyl)-11-oxabicyclo[8.1.0]undec-6-en-4-yl ester, (2E)
Mitrinermine
C22H28N2O4 (384.20489680000003)
Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research. Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research.
7alpha-Voacangine hydroxyindolenine
C22H28N2O4 (384.20489680000003)
Annotation level-1
5-[(Z)-12-(3,5-dihydroxyphenyl)dodec-8-enyl]benzene-1,3-diol_major
Ala Ala His Ser
Ala Ala Ser His
Ala Gly His Thr
Ala Gly Thr His
Ala His Ala Ser
Ala His Gly Thr
Ala His Ser Ala
Ala His Thr Gly
Ala Pro Pro Thr
Ala Pro Thr Pro
Ala Pro Val Val
C18H32N4O5 (384.23725820000004)
Ala Ser Ala His
Ala Ser His Ala
Ala Thr Gly His
Ala Thr His Gly
Ala Thr Pro Pro
Ala Val Pro Val
C18H32N4O5 (384.23725820000004)
Ala Val Val Pro
C18H32N4O5 (384.23725820000004)
Gly Ala His Thr
Gly Ala Thr His
Gly His Ala Thr
Gly His Thr Ala
Gly Ile Pro Val
C18H32N4O5 (384.23725820000004)
Gly Ile Val Pro
C18H32N4O5 (384.23725820000004)
Gly Leu Pro Val
C18H32N4O5 (384.23725820000004)
Gly Leu Val Pro
C18H32N4O5 (384.23725820000004)
Gly Pro Ile Val
C18H32N4O5 (384.23725820000004)
Gly Pro Leu Val
C18H32N4O5 (384.23725820000004)
Gly Pro Val Ile
C18H32N4O5 (384.23725820000004)
Gly Pro Val Leu
C18H32N4O5 (384.23725820000004)
Gly Thr Ala His
Gly Thr His Ala
Gly Val Ile Pro
C18H32N4O5 (384.23725820000004)
Gly Val Leu Pro
C18H32N4O5 (384.23725820000004)
Gly Val Pro Ile
C18H32N4O5 (384.23725820000004)
Gly Val Pro Leu
C18H32N4O5 (384.23725820000004)
His Ala Ala Ser
His Ala Gly Thr
His Ala Ser Ala
His Ala Thr Gly
His Gly Ala Thr
His Gly Thr Ala
His Ser Ala Ala
His Thr Ala Gly
His Thr Gly Ala
Ile Gly Pro Val
C18H32N4O5 (384.23725820000004)
Ile Gly Val Pro
C18H32N4O5 (384.23725820000004)
Ile Pro Gly Val
C18H32N4O5 (384.23725820000004)
Ile Pro Val Gly
C18H32N4O5 (384.23725820000004)
Ile Val Gly Pro
C18H32N4O5 (384.23725820000004)
Ile Val Pro Gly
C18H32N4O5 (384.23725820000004)
Leu Gly Pro Val
C18H32N4O5 (384.23725820000004)
Leu Gly Val Pro
C18H32N4O5 (384.23725820000004)
Leu Pro Gly Val
C18H32N4O5 (384.23725820000004)
Leu Pro Val Gly
C18H32N4O5 (384.23725820000004)
Leu Val Gly Pro
C18H32N4O5 (384.23725820000004)
Leu Val Pro Gly
C18H32N4O5 (384.23725820000004)
Pro Ala Pro Thr
Pro Ala Thr Pro
Pro Ala Val Val
C18H32N4O5 (384.23725820000004)
Pro Gly Ile Val
C18H32N4O5 (384.23725820000004)
Pro Gly Leu Val
C18H32N4O5 (384.23725820000004)
Pro Gly Val Ile
C18H32N4O5 (384.23725820000004)
Pro Gly Val Leu
C18H32N4O5 (384.23725820000004)
Pro Ile Gly Val
C18H32N4O5 (384.23725820000004)
Pro Ile Val Gly
C18H32N4O5 (384.23725820000004)
Pro Pro Ala Thr
Pro Pro Thr Ala
Pro Thr Ala Pro
Pro Thr Pro Ala
Ser Ala Ala His
Ser Ala His Ala
Ser His Ala Ala
Thr Ala Gly His
Thr Ala His Gly
Thr Ala Pro Pro
Thr Gly Ala His
Thr Gly His Ala
Thr His Ala Gly
Thr His Gly Ala
Thr Pro Ala Pro
Thr Pro Pro Ala
(22E)-12α-Hydroxy-3-oxochola-1,4,22-trien-24-oic Acid
JWH-200
C25H24N2O2 (384.18376839999996)
Bortezomib
C19H25BN4O4 (384.19687600000003)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XG - Proteasome inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor D000970 - Antineoplastic Agents C471 - Enzyme Inhibitor
(6beta,7alpha,12beta,13beta)-7-Hydroxy-11,16-dioxo-8,14-apianadien-22,6-olide
Cinnzeylanol
Armillarivin
Berkeleylactone E
Berkeleylactone K
Cardiogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides
1-(2,4,6-Trihydroxyphenyl)-6Z,9Z,12Z,15Z-octadecatetraen-1-one
N-(2-benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide
C25H24N2O2 (384.18376839999996)
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
C19H25BN4O4 (384.19687600000003)
1-BOC-4-(CARBOXY-NAPHTHALEN-2-YL-METHYL)-[1,4]DIAZEPANE
C22H28N2O4 (384.20489680000003)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N,N-bis(phenylmethyl)- (9CI)
C24H24N4O (384.19500139999997)
benzyl 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-ylcarbamate
C20H25BN2O5 (384.18564299999997)
(3-BOC-AMINO-AZETIDIN-1-YL)-PYRIDIN-3-YL-ACETICACID
C22H28N2O4 (384.20489680000003)
(s)-1-cbz-amino-2-boc-amino-3-phenyl-propane
C22H28N2O4 (384.20489680000003)
bis[3-(trimethoxysilyl)propyl]ethylene diamine
C14H36N2O6Si2 (384.21117960000004)
4-Fluorophenyl 4-(trans-4-propylcyclohexyl carbonyloxy)benzoate
TERT-BUTYL 4-((3-(CYCLOPROPYLAMINO)QUINOXALIN-2-YL)OXY)PIPERIDINE-1-CARBOXYLATE
Istradefylline
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent N - Nervous system > N04 - Anti-parkinson drugs Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson's disease.
(4-BENZYL-MORPHOLIN-2-YL)-ACETICACIDMETHYLESTER
C22H28N2O4 (384.20489680000003)
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-[(4-fluorophenyl)methyl]-N-(2-methylpropyl)- (9CI)
1-(2,6-Diisopropylphenyl)-3-(2,4,6-trimethylphenyl)-4,5-dihydroimidazolium chloride
C24H33ClN2 (384.23321280000005)
methyl 2-(2-(benzyloxycarbonylamino)-(1,3-d6-propan)-2-yl)-5-hydroxy-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidine-4-carboxylate
(S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoic acid
C17H28N4O4S (384.18311680000005)
Boronic acid, B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)aMino]propyl]aMino]butyl]-
C19H25BN4O4 (384.19687600000003)
(S)-Valganciclovir DiMethyl Ether IMpurityDISCONTINUED
(3aS,3aS,8aR,8aR)-2,2-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
C25H24N2O2 (384.18376839999996)
L-Phenylalanine, N-[(2R,3R)-3-methoxy-2-methyl-1-oxo-3-(2S)-2-pyrrolidinylpropyl]-, methyl ester, monohydrochloride (9CI)
C19H29ClN2O4 (384.18157440000004)
2,2,2-TRIFLUORO-1-(4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PIPERAZIN-1-YL)ETHANONE
C18H24BF3N2O3 (384.18319799999995)
2-Despiperidyl-2-amino Repaglinide
C22H28N2O4 (384.20489680000003)
2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxy-N-methylanilino)methyl]pyrido[2,3-D]pyrimidine
C19H24N6O3 (384.19097939999995)
rac-2-Despiperidyl-2-amino Repaglinide
C22H28N2O4 (384.20489680000003)
(2E,8R)-8-({3,6-dideoxy-4-O-[(2E)-2-methylbut-2-enoyl]-alpha-L-arabino-hexopyranosyl}oxy)non-2-enoic acid
Desfuranoazadiradione
A limonoid that is azadiradione in which the furanyl group at position 17 is replaced by a hydrogen. It has been isolated from Azadirachta indica.
plakortolide R
An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.
Estra-1,3,5(10)-triene-3,16alpha-diol, dipropionate
1-[4-(Benzyloxy)-3-methoxyphenyl]-5-hydroxydecan-3-one
3-(5-{[4-(Aminomethyl)piperidin-1-Yl]methyl}-1h-Indol-2-Yl)-1h-Indazole-6-Carbonitrile
6-[N-(1-Isopropyl-3,4-dihydro-7-isoquinolinyl)carbamyl]-2-naphthalenecarboxamidine
C24H24N4O (384.19500139999997)
Ethynodiol Diacetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Estradiol dipropionate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Methyl 17-(1-hydroxyethyl)-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate
C22H28N2O4 (384.20489680000003)
[(2S,3As,7aS)-Octahydro-1-[[(1R,2R)-2-phenylcyclopropyl]carbonyl]-1H-indol-2-yl]-3-thiazolidinyl--methanone
3-Hydroxy-16-methoxy-2,3-dihydrotabersonine
C22H28N2O4 (384.20489680000003)
methyl (1R,10S,11R,12R,19R)-12-ethyl-10,11-dihydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
C22H28N2O4 (384.20489680000003)
(E)-7-[3-[(E)-3-hydroxy-4-phenylpent-1-enyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid
Perimetazine
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
[(1R,2R,3S,4R,6E,10S)-2-hydroxy-6,10-dimethyl-3-propan-2-yl-11-oxabicyclo[8.1.0]undec-6-en-4-yl] (E)-3-phenylprop-2-enoate
[4-(2,3-Dimethylphenyl)-1-piperazinyl]-(3,4,5-trimethoxyphenyl)methanone
C22H28N2O4 (384.20489680000003)
acetic acid [(17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] ester
(2S)-2-[[(2S)-2-amino-1-oxopropyl]amino]-3-methyl-N-[(2S)-1-(1-naphthalenylamino)-1-oxopropan-2-yl]butanamide
2-[(2-amino-1-oxopropyl)amino]-3-methyl-N-[1-(1-naphthalenylamino)-1-oxopropan-2-yl]butanamide
[(2S,4aS,10aR)-6-acetyloxy-1,1,4a-trimethyl-7-propan-2-yl-2,3,4,10a-tetrahydrophenanthren-2-yl] acetate
1-[(3aS,4S,9bR)-8-(4-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-methoxyethanone
1-[(3aR,4R,9bS)-8-(4-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-methoxyethanone
(1S,5R)-3-[(3-fluorophenyl)methyl]-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane
C26H25FN2 (384.20016619999996)
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(oxane-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-1-propyl-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(oxane-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-1-propyl-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
2-fluoro-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]-N-methylbenzamide
N-[[(2S,3R,4R)-1-acetyl-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylacetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
1-[(3aR,4S,9bS)-8-(4-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-methoxyethanone
(1R,5S)-6-[(3-methoxyphenyl)methyl]-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
2-fluoro-N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]-N-methylbenzamide
2-fluoro-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]-N-methylbenzamide
N-[[(2R,3S,4S)-1-acetyl-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylacetamide
N-[[(2R,3R,4S)-1-acetyl-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylacetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
1-[(3aS,4R,9bR)-8-(4-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-methoxyethanone
(1S,5R)-3-[(3-methoxyphenyl)methyl]-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
13,14-dihydro-15-oxo-20-carboxy-PGF2alpha
A member of the class of prostaglandins Falpha that is 15-oxo-prostaglandin F2alpha in which the methyl group has been oxidised to the corresponding carboxylic acid and in which the double bond at positions 13-14 has been reduced to a single bond.
(5S,6Z,8E,10E,12R,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,10,14-tetraenoic acid
4-oxo-4-[[(1S,4S,5R,8S,9R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxy]butanoic acid
[(8S,9R,10S,13R,14R,17S)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
3,4,5-Trihydroxy-6-[1-(4-methoxyphenyl)-4-methylpentan-3-yl]oxyoxane-2-carboxylic acid
6-[4-[1-(2-hydroxycyclohexyl)-2H-tetrazol-1-ium-5-yl]butoxy]-1H-quinolin-2-one
C20H26N5O3+ (384.2035546000001)
(2Z,10Z,12E,14Z)-16-(3,5-dihydroxyphenyl)-2-ethylidenehexadeca-10,12,14-trienoic acid
6-[4-[1-(4-hydroxycyclohexyl)-2H-tetrazol-1-ium-5-yl]butoxy]-1H-quinolin-2-one
C20H26N5O3+ (384.2035546000001)
O-(2-O-Octanoyl-L-glycero-3-phospho)choline
C16H35NO7P+ (384.21510300000006)
2-[Hydroxy-(2-hydroxy-3-octanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
C16H35NO7P+ (384.21510300000006)
[(8R,9R,10R,13S,14S,17S)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
6-Acetoxy-2,5,7,8-tetramethyl-2-[2-(phenylthio)ethyl]-3,4-dihydro-2H-1-benzopyran
2-[(3-Acetyloxy-2-pentanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Butanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
Methyl (1S,10R,12R,19S)-12-ethyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
C22H28N2O4 (384.20489680000003)
Scillarenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides
mbas#3
A 4-O-[(E)-2-methyl-2-butenoyl]ascaroside derived from (2E,8R)-8-hydroxynon-2-enoic acid. It is a metabolite of the nematode Caenorhabditis elegans.
12alpha-Hydroxy-3-oxochola-1,4,6-trien-24-oic Acid
[3-Methyl-1-[[1-oxo-2-[[oxo(2-pyrazinyl)methyl]amino]-3-phenylpropyl]amino]butyl]boronic acid
C19H25BN4O4 (384.19687600000003)
soppiline C
A member of the class of resorcinols that is 16-(3,5-dihydroxyphenyl)hexadecanoic acid which carries cis double bonds at positions 10 and 14, a trans double bond at position 12, and an ethylidene group at position 2.
AR-M 1000390 (hydrochloride)
AR-M 1000390 hydrochloride is an exceptionally selective, potent δ opioid receptor agonist with an EC50 of 7.2±0.9 nM for δ agonist potency.
FASN-IN-3
C24H24N4O (384.19500139999997)
FASN-IN-3 is a fatty acid synthase (FASN) inhibitor extracted from patent US20170119786A1, compound 242A[1].
TVB-3166
C24H24N4O (384.19500139999997)
TVB-3166 is an orally-available, reversible, and selective fatty acid synthase (FASN) inhibitor with IC50s of 42 nM and 81 nM for biochemical FASN and cellular palmitate synthesis, respectively. TVB-3166 induces apoptosis, and inhibits in-vivo xenograft tumor growth[1].
methyl (1s,15r,17s,18s)-17-[(1s)-1-hydroxyethyl]-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C22H28N2O4 (384.20489680000003)
methyl 6-methoxy-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C22H28N2O4 (384.20489680000003)
methyl (2z)-2-[(3s,6's,7'r,8'ar)-6'-ethyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl]-3-methoxyprop-2-enoate
C22H28N2O4 (384.20489680000003)
methyl 5-{8-[6-(methoxycarbonyl)pyridin-3-yl]octyl}pyridine-2-carboxylate
C22H28N2O4 (384.20489680000003)
(1s,13r,14s,19r)-10-hydroxy-1,14,18,18-tetramethyl-2,6-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3(11),4(8),9-triene-7,17-dione
7'',8''-dihydroxy-6''-(hydroxymethyl)-2,6,6-trimethyl-3'',4''a,6'',7'',8'',8''a-hexahydrodispiro[cyclohexane-1,2'-oxolane-5',2''-pyrano[2,3-b][1,4]dioxin]-2-en-4-one
methyl (1s,15s,18r,19s,20r)-18-hydroxy-8-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C22H28N2O4 (384.20489680000003)
5-[(1r,3as,3br,5as,9ar,9bs,11ar)-3a,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pyran-2-one
10-hydroxy-1,14,18,18-tetramethyl-2,6-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10-triene-7,17-dione
(1s,3s,7r,7as)-4-[(acetyloxy)methyl]-7-(hydroxymethyl)-3,7-dimethoxy-1h,3h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
methyl (1s,15s,17s,18s)-17-[(1r)-1-hydroxyethyl]-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
C22H28N2O4 (384.20489680000003)
2,10,11-trihydroxy-2,6,11-trimethyl-7-oxo-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-4-yl 2-methylpropanoate
methyl (1r,15s,18s,19s,20r)-18-hydroxy-6-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C22H28N2O4 (384.20489680000003)
methyl 17-hydroxy-6-methoxy-10,13-diazapentacyclo[11.8.0.0³,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-3(11),4,6,8-tetraene-16-carboxylate
C22H28N2O4 (384.20489680000003)
methyl (2e)-2-[(2s,3r,12bs)-3-ethyl-9-hydroxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
C22H28N2O4 (384.20489680000003)
(1s,2s,4ar,8ar)-1-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl (2s,3s)-2,3-dihydroxy-2-methylbutanoate
methyl (2e)-2-[(6's,7's)-6'-ethyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl]-3-methoxyprop-2-enoate
C22H28N2O4 (384.20489680000003)
methyl (1s,15s,18r,19r,20s)-18-hydroxy-8-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C22H28N2O4 (384.20489680000003)
hydroxy(3-hydroxy-5-oxo-4-tetradecanoyl-2h-furan-2-yl)acetic acid
19-methoxy-10,10-dimethyl-9,11-dioxatetracyclo[15.3.1.1²,⁶.0⁸,¹²]docosa-1(20),2(22),3,5,17(21),18-hexaene-3,20-diol
methyl (1s,15s,18r,19s,20s)-18-hydroxy-8-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C22H28N2O4 (384.20489680000003)
2-hydroxy-2-[(2e,6e)-8-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-methyl-1-benzofuran-3-one
(1r,3as,6s,7r,7ar)-6-isopropyl-1,3a-dimethyl-7-{[(2e)-3-phenylprop-2-enoyl]oxy}-hexahydro-2h-indene-1-carboxylic acid
12-methoxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-10h-1,5,9-trioxatriphenylen-2-one
methyl (1s,9r,16r,18r,21s)-18-hydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
C22H28N2O4 (384.20489680000003)
(3r,3as,4s,8ar)-3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
2-methylpropyl 13-(2h-1,3-benzodioxol-5-yl)trideca-2,4,12-trienoate
9-decanoyl-3,6a-dimethylfuro[2,3-h]isochromene-6,8-dione
methyl (1s,15r,18s,19r,20s)-18-hydroxy-7-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C22H28N2O4 (384.20489680000003)
methyl (3r,4s,5r)-3-(acetyloxy)-5-{[(3s)-3-methylpentanoyl]oxy}-4-(propanoyloxy)cyclohex-1-ene-1-carboxylate
11-(acetyloxy)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-3-yl acetate
5-(acetyloxy)-6-isopropyl-12,12-dimethyltricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7-tetraen-4-yl acetate
8-hydroxy-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl 4-hydroxyoct-2-enoate
(1'r,2r,3r,4s,11'r,12's)-4,5,5,6',10',12'-hexamethyl-14'-oxaspiro[oxolane-2,13'-tetracyclo[9.3.2.0¹,¹⁰.0²,⁷]hexadecane]-2'(7'),3',5',8'-tetraene-3,5'-diol
(9r,13r,14r,16s,17r)-16-acetyl-14-hydroxy-8,8,13,17-tetramethyl-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-trien-6-one
3-[(1s,12s,13r,14r)-13-(hydroxymethyl)-3,16-dimethyl-3,16-diazatetracyclo[10.3.1.0²,¹⁰.0⁴,⁹]hexadeca-2(10),4,6,8-tetraen-14-yl]-4-oxopentanoic acid
C22H28N2O4 (384.20489680000003)
methyl (2e)-2-[(6'r,7's,8'as)-6'-ethyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl]-3-methoxyprop-2-enoate
C22H28N2O4 (384.20489680000003)
(1s,2r,4s)-5-{2-[(2r,5r)-2,5-dimethyl-5-[2-(4-methylphenyl)ethenyl]oxolan-2-yl]ethenyl}-2-methylcyclohex-5-ene-1,2,4-triol
(1r,3r,4s,7s,8s,9r,11s,12s)-11-(acetyloxy)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-3-yl acetate
(1r,2r,4s,5r,6s,9s,10r,11s,13s)-2,10,11-trihydroxy-2,6,11-trimethyl-7-oxo-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-4-yl 2-methylpropanoate
(1r,2e,8z,10z,14z,17r)-3,11-dimethyl-19-methylidene-7,13-dioxo-6,21-dioxabicyclo[15.3.1]henicosa-2,8,10,14-tetraene-5-carbaldehyde
1-{1-[2-(2-hydroxy-6-methylphenyl)-2-oxoethyl]-4,7-dimethyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-3-yl}-3-methylbutan-1-one
(1r,4s,8r,10r,11s,12s)-10-hydroxy-4-isopropyl-7,13,13-trimethyl-18-oxapentacyclo[9.5.2.0¹,¹².0²,⁹.0⁴,⁸]octadeca-2(9),6-diene-3,5,17-trione
(1s,2r,4s,5r,6s,9s,10s,11s,12s,13r)-2,11,12-trihydroxy-2,6,11-trimethyl-7-oxo-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-4-yl 2-methylpropanoate
methyl (1s,15s,18r,19s,20r)-18-hydroxy-6-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
C22H28N2O4 (384.20489680000003)